Sorrento Therapeutics, Inc.
Anti-KRAS binding proteins
Last updated:
Abstract:
The present disclosure provides anti-KRAS antibodies, and antigen-binding fragments thereof. In certain embodiments, the anti-KRAS antibodies or fragments thereof, are used for the treatment of cancer.
Status:
Grant
Type:
Utility
Filling date:
10 Apr 2019
Issue date:
16 Nov 2021